PMHS logo

Polomar Health Services, Inc. Stock Price

OTCPK:PMHS Community·US$2.2m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

PMHS Share Price Performance

US$0.08
-0.17 (-68.00%)
US$0.08
-0.17 (-68.00%)
Price US$0.08

PMHS Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Medium-low risk and slightly overvalued.

6 Risks
0 Rewards

Polomar Health Services, Inc. Key Details

US$37.0k

Revenue

US$16.6k

Cost of Revenue

US$20.4k

Gross Profit

US$2.5m

Other Expenses

-US$2.4m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
-0.087
55.09%
-6,562.42%
12.8%
View Full Analysis

About PMHS

Founded
n/a
Employees
3
CEO
Terrence Tierney
WebsiteView website
polomarsp.com

Polomar Health Services, Inc. operates as a retail compounding pharmacy. The company owns SlimRx, a weight loss focused online platform connects patients with licensed physicians to prescribe weight loss medications, such as semaglutide compounded with vitamin B-12 and/or metformin; and intends to launch PoloMeds for diabetes medications, including metformin compounds, sulfonylureas, and insulin, as well as compounded erectile dysfunction medications inhalable sildenafil. It also includes dermatological formulations for the treatment of acne, alopecia areata, basal cell carcinoma, Becker’s nevus, vitiligo, and other common skin conditions. In addition, it provides prescription fulfillment services for third party web based tele-health platforms. The company is based in Los Angeles, California.

Recent PMHS News & Updates

Recent updates

No updates